Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-24-000062
Filing Date
2024-07-31
Accepted
2024-07-31 16:31:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4875
  Complete submission text file 0001974158-24-000062.txt   6345
Mailing Address 5871 OBERLIN DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Heyman Richard A. (Reporting) CIK: 0001584759 (see all company filings)

Type: 144

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Subject) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39247 | Film No.: 241162500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)